drugset / Trial / NCT02581397
Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive Cough
RandomizedParallel-groupOpen-labelTreatment
Summary
This study evaluates the non-inferiority of Suppository Transpulmin and Suppository Guaiacol compared to Transpulmin Syrup in the treatment of cough with secretion of infectious origin in children between two and six years old. One third of participants will receive Suppository Transpulmin, the other one third will receive Suppository Guaiacol and the last one third will receive Transpulmin Syrup.
Timeline
- Start
- 2015-05-05
- Primary completion
- 2016-12-06
- Completion
- 2016-12-06
Outcome
Outcome not reported
Stopped: “The study stopped because after monitoring visits and data analysis we noticed a high number of protocol deviation that made impossible the results analysis.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guaiacol | Small molecule | 1 unknown | Rectal |
| Comparator | Guaifenesin | Small molecule | 7.5 ml | Oral |
| Subject | Menthol | Small molecule | 1 unknown | Rectal |
| Subject | camphor | Unknown | 1 unknown | Rectal |
| Subject | eucalyptol | Small molecule | 1 unknown | Rectal |
Indications
No indication recorded.